Reactivos de laboratorio para uso in vitro
categoriaProducto: Commercials
modalidad: Laboratory Reagents
producidoPor: CIM
BLOOD TYPING
COOMBS SERUM
CONJUGATED LEUCOCITARY MARKERS
nombreComercial: - ior® Hemo-CIM SC Anti-A - ior® Hemo-CIM SC Anti-B - ior® Hemo-CIM SC Anti-AB - ior® Hemo-CIM SC Anti-D/SUERO DE COOMBS®/- ior® anti-CD3 humano-FITC - ior® anti-CD4 humano-FITC - ior® anti-CD4 humano-PE - ior® anti-CD8 humano-FITC - ior® anti-CD45 humano-FITC
formaFarmaceutica: NP
propiedadesFarmacologicas: Blood typing reagents for the determination of blood groups of the ABO system and Rh system, formulated from murine monoclonal antibodies. Coombs serum is a polyspecifi c human antiglobulin serum used in immunodiagnostics in the study of patients suffering from autoimmune hemolytic anemia and other autoimmune diseases. It is used for the detection of fetal maternal Rh confl icts (hemolytic disease of the newborn); in the determination of blood group antigens (Du test) and in pre-transfusion tests for the identifi cation of erythrocyte antibodies in human serum and in red blood cells sensitized in vivo. Human ior® anti-CD reagents are primary conjugates for fl ow cytometry that recognize the human CD3, CD4, CD8 and CD45 molecule respectively. Its main applications are for the counting of lymphocyte populations during the evaluation of leukemia, lymphomas, immunodefi ciencies and other diseases of the Immune System, as well as in the monitoring of the immune system of patients undergoing any type of immunotherapy.
indicacionesTerapeuticas: Uso laboratorio
aprobacionesEspecialesComercializacion: Cuba
Frequent Questions
How can I access the therapeutic vaccines against lung cancer?
Cuba has 2 therapeutic vaccines for advanced lung cancer:
CIMAvax EGF ® and VAXIRA ® (racotumomab). Both therapeutic vaccines have sanitary registration in the indication of stage III and IV advanced non-small cell lung cancer (NSCLC), after the first line of chemotherapy. The main clinical benefit of these vaccines has been shown to be increased survival and improved quality of life, as well as a broad safety profile.
How to acquire the vaccines?
Foreigners should contact the Cuban Medical Services who will evaluate each case as part of a comprehensive patient care program, with commercial value.
-Cuban Medical Services. Web page:
www.smcsalud.cu.; E-mail: smc@smcsalud.cu
Phone: (537) 209-0977 Fax: (537) 203-1590.
You can also make your request for care expressing the reason for your request, a medical summary and personal data directly to:
International Clinic of the Hermanos Ameijeiras Hospital.
Calle San Lázaro # 701 esq. to Belascoaín, Havana Center, Havana, C.P: 10400, Cuba.
Telephone: (537) 8761029, (537) 8761030, (537) 8761683. Email: turismomedico@hha.sld.cu
International Health Center
La Pradera Calle 15 between 222 A and 234, Siboney neighborhood, Playa Municipality, Havana, Cuba
Telephone: (+537) 273 7467 Ext. 403 (+537) 2737202. Email: comercia@cislapradera.cu